Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jul;19(7):1138-41.
doi: 10.3201/1907.130313.

Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection

Affiliations
Case Reports

Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection

Suzanne M Hingley-Wilson et al. Emerg Infect Dis. 2013 Jul.

Abstract

Infections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mixed infection. Diagnostic techniques that identify mixed tubercle bacilli populations are needed to curb the spread of multidrug resistance.

Keywords: Mycobacterium tuberculosis; TB; antimicrobial resistance; bacteria; co-infection; drug sensitive; multidrug resistant; treatment resistance; tuberculosis and other mycobacteria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mycobacterium tuberculosis co-culture competition experiment in a study of the amplification of multidrug resistance induced by first-line treatment of a mixed M. tuberculosis infection. The results suggest competitive advantages in vitro, which may account for patient strain phenotype in vivo. S, drug sensitive; R, drug resistant; OADC, oleic acid, albumin, dextrose, catalase growth supplement; OD600, optical density read at 600 nm; −INH, without isoniazid; +INH, with INH; MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number tandem repeat; CFU, colony-forming units.
Figure 2
Figure 2
Analyses of the amplification of multidrug-resistant Mycobacterium tuberculosis during treatment of a drug-sensitive (S) strain in a mixed infection (i.e., infection with drug-resistant [R] and S strains). In the presence of isoniazid (INH), the faster growing S strain lost its competitive advantage, and the R strain became more prevalent. A–C) Data are means of 3 independent replicates with SE bars. A) Single strain growth analyses of S (black circles) and R (gray triangles) M. tuberculosis strains. Growth was measured by optical density at 600 nm (OD600). *p<0.05. B) Competitive growth analyses of mixed strains alone (black squares) and with 0.2 μg/mL INH (gray triangles). Growth, in triplicate, in 7H9 broth plus OADC (oleic acid, albumin, dextrose, and catalase growth supplement), glycerol, and Tween 80 was measured by optical density at OD600. Statistical analyses were performed on triplicate samples by using 2-way analysis of variance. *p<0.05. C) Identification of the predominant strain in mixed cultures with and without 0.2 μg/mL INH (INH/plate+ and INH/plate−, respectively). Strains were identified on day 7 by plating a 10-fold dilution series of co-cultures onto 7H10 agar, plus OADC and glycerol, with or without 0.2 μg/mL INH (0/plate+ and 0/plate−, respectively) and incubating for 2 weeks at 37°C. Statistical analyses were conducted on triplicate samples by using a 2-tailed t-test. *p<0.02. CFU, colony-forming units.

References

    1. Mendez MP, Landon ME, McCloud MK, Davidson P, Christensen PJ. Co-infection with pansensitive and multidrug-resistant strains of Mycobacterium tuberculosis. Emerg Infect Dis. 2009;15:578–80 . 10.3201/eid1504.080592 - DOI - PMC - PubMed
    1. van Rie A, Victor TC, Richardson M, Johnson R, van der Spuy GD, Murray EJ, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005;172:636–42 . 10.1164/rccm.200503-449OC - DOI - PMC - PubMed
    1. Martín A, Herranz M, Ruiz Serrano MJ, Bouza E, Garcia de Viedma D. The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture. Tuberculosis (Edinb). 2010;90:201–7. 10.1016/j.tube.2010.03.012 - DOI - PubMed
    1. Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, Gey van Pittius NC, et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004;169:610–4 . 10.1164/rccm.200305-714OC - DOI - PubMed
    1. Wang JY, Hsu HL, Yu MC, Chiang CY, Yu FL, Yu CJ, et al. Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain. Clin Microbiol Infect. 2011;17:1239–45. 10.1111/j.1469-0691.2010.03401.x - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources